Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Use of New DMARDs for JIA Rose Steadily in Past 20 Years
The use of newer biologic or targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs) for treating juvenile idiopathic arthritis (JIA) rose sharply from 2001 to 2022, while the use of conventional synthetic DMARDs (csDMARDs) plummeted, with adalimumab becoming the most commonly used…
English